Vanda Pharmaceuticals Inc. Insider Trading for January 2017

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Vanda Pharmaceuticals Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Vanda Pharmaceuticals Inc. for January 2017.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.005,000010,000
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.005,00005,000
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.002,34400
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...SellS15.5110,895169,01369,72180.6 K to 69.7 K (-13.51 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.007,500080,61673.1 K to 80.6 K (+10.26 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.005,000073,11668.1 K to 73.1 K (+7.34 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.005,000068,11663.1 K to 68.1 K (+7.92 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.002,344063,11660.8 K to 63.1 K (+3.86 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0018,750056,250
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500025,000
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500012,500
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.006,25000
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.4823,330361,242850,848874.2 K to 850.8 K (-2.67 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0018,7500874,178855.4 K to 874.2 K (+2.19 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000855,428842.9 K to 855.4 K (+1.48 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000842,928830.4 K to 842.9 K (+1.51 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.006,2500830,428824.2 K to 830.4 K (+0.76 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,000010,000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,00005,000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.0012,50000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyS15.5116,300252,77654,36538.1 K to 54.4 K (+42.82 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.007,500070,66563.2 K to 70.7 K (+11.87 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000063,16558.2 K to 63.2 K (+8.60 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000058,16553.2 K to 58.2 K (+9.40 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.0012,500053,16540.7 K to 53.2 K (+30.74 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.0012,500037,500
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...SellS15.5110,900169,0909,10020 K to 9.1 K (-54.50 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.007,500020,00012.5 K to 20 K (+60.00 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.0012,500012,5000 to 12.5 K
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.0012,500037,500
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.007,500020,00012.5 K to 20 K (+60.00 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.0012,500012,5000 to 12.5 K

Contact us | Follow us on Twitter